`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 1 of 9 PageID #: 1094
`es
`
`
`
`tfTy. ~ ncicistene
`
`—H:
`cee
`
`eee
`
`
`
`MAR
`O°
`BNO
`i
`MAK og 2023
`|
`Pilireeset
`3 D'STRICT COURT
`_T OF DELAWARE
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`ARBUTUS BIOPHARMA
`CORPORATION AND GENEVANT
`SCIENCES GMBH,
`
`)Case No.: 22-cv-00252-MSG
`)
`)
`Plaintiffs,)
`
`V.
`
`MOTION TO INTERVENE
`
`PROPOSED CLASS ACTION
`
`MODERNA,INC. and MODERNATX,
`INC.
`
`Defendants.
`
`EMANUEL MCCRAY,OnBehalfof
`Himselfand All Others Similarly Situated,
`
`Intervenors-Plaintiffs.Neeeeee
`
`Emanuel McCray (“McCray”), Proposed Intervenor, respectfully moves to
`
`intervene in this action on behalf of himself and all other citizens of the United
`
`States similarly situated, as a class, pursuant to Rule 24 of the Federal Rules of Civil
`
`Procedure (Fed. R. Civ. P.), our sovereign powers reserved to the People in the
`
`|
`
`
`
`Cage 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 2 of 9 PagelD #: 1095
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 2 of 9 PageID #: 1095
`
`oOo©NNDneHF&FWwNHN—
`
`BSBDBOBOKDBDNONDORDleeSleaoNSDOASeWYNY|CFSOoFeNDBHOARFFWYNY—-S&S
`
`Tenth Amendment, and our poweras a group acting as a class pursuant to Bondv.
`
`United States, 572 U.S. 844, 853 (2014),! and Califano v. Yamasaki, 442 U.S. 682,
`
`700, (1979).?
`
`This Motion is supported by the attached Memorandum of Law. A Proposed
`
`Complaint for declaratory relief as the pleading required under Rule 24
`
`accompanies this Motion To Intervene.
`
`For the reasonsset forth in the attached Complaint, intervention is warranted
`
`as of right or permission because Intervenor McCray was born in the United States
`
`and the proposed class members were either born or naturalized in the United
`
`States, were subjected to the claimed “pandemic”; the measures to control the
`
`pandemic; and the vaccines produced by the Defendants were for McCray and the
`
`other putative class members.
`
`’ Holding that: “‘An individual may ‘assert injury from governmental action taken in excess of the authority
`that federalism defines.””
`? Holding that“class relief is appropriate in civil actions brought in federal court, including those seeking to
`overturn determinations of the departments of the Executive Branch of the Government in cases where judicial review
`of such determinationsis authorized.... Indeed, a wide variety of federal jurisdictional provisions speak in terms of
`individual plaintiffs, but class relief has never been thought to be unavailable under them.”
`
`2
`
`
`
`Cage
`1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 3 of 9 PagelD #: 1096
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 3 of 9 PageID #: 1096
`
`—
`
`4
`
`MEMORANDUM OF LAW IN SUPPORT OF MOTION TO INTERVENE
`
`I,
`
`Legal Standard.
`
`The proposed Intervenors-Plaintiffs seek intervention (i) as ofright or (ii)
`
`5||permissively, solely to challenge Moderna’s attemptto shift liability forits
`
`“Prototype Pathogen” vaccines to the United States, which would violate the
`
`g||sovereignty of the United States and the individual sovereignty of the People
`
`9||reserved in the Tenth Amendment.
`
`10
`
`Whatdistinguishes intervention from other methods of adding new partiesis
`
`12.||that it requires action by an outside party whoseeksa seatat the table. See 7C
`
`13||Charles Alan Wright et al., Federal Practice and Procedure § 1901, at 257-60 (3d
`
`ed. 2007).
`
`The Third Circuit has held that:
`
`“[A]litigant seeking intervention as of right under Rule 24(a)(2) must
`establish 1) a timely application for leave to intervene, 2) a sufficient
`interest in the underlyinglitigation, 3) a threat that the interest will be
`impaired or affected by the disposition of the underlying action, and 4)
`that the existing parties to the action do not adequately represent the
`prospective intervenor’s interests. Liberty Mut. Ins. Co. v. Treesdale,
`Inc., 419 F.3d 216, 220 (3d Cir. 2005)(citing Kleissler v. United States
`Forest Service, 157 F.3d 964, 969 (3d Cir. 1998)). ‘Each of these
`requirements must be metto intervene as ofright.’” 419 F.3d at 220
`(citing Mountain Top Condominium Assoc. v. Dave Stabbert Master
`Builder, Inc., 72 F.3d 361, 366 (3d Cir. 1995).
`
`15
`
`16
`
`17
`18
`
`19
`20
`
`21
`22
`
`23
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`Caffe 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 4 of 9 PagelD #: 1097
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 4 of 9 PageID #: 1097
`
`Il.
`
`The Third Circuit’s Requirements for Intervention Have Been Met.
`
`This Motion to Intervene is timely. The Plaintiffs’ Complaint was filed on
`
`February 28, 2022 (Doc. 1).
`
`On November2, 2022, (Doc. 32), Judge Goldberg denied Moderna’s motion
`
`to dismiss and directed that: “Within fourteen (14) days from the date of this Order,
`
`Defendants shall file an answer to the Complaint.”
`
`On November30, 2022, Moderna filed an Answerto Plaintiffs’ Complaint,
`
`which was accompaniedby a counterclaim against the Plaintiffs (Doc. 35).
`
`On December21, 2022, Plaintiffs filed an Answer to Defendants’
`
`counterclaim (DOC. 38). On February 14, 2023, the United States filed a Statement
`
`of Interest (Doc. 49). On February 16, 2023, Judge Goldberg filed an Order
`
`directing that: “Within fourteen (14) days from the date of this Order, the parties
`
`and the U.S. Governmentshall submit a letter of no more than ten pages regarding
`
`the impact of the Governments Statement of Interest on the scheduling of this
`
`matter.” (Doc. 51).
`
`Asofthe date of this Motion, February 26, 2023, the United States and the
`
`existing parties have not filed the letters mandated by Judge Goldberg on February
`
`16, 2023. Thus, timeliness required by the Third Circuit has been met.
`
`Asstated supra and infra, and in the attached Intervenors’ Complaint,
`
`Intervenors havea significant interest in the underlyinglitigation. Whether Moderna
`
`
`
`Cage 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 5 of 9 PagelD #: 1098
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 5 of 9 PageID #: 1098
`
`—OooonNDHvAS&SWWW
`
`can shift its liability for vaccines based on a “prototype pathogen”that required
`
`infringementofPlaintiffs’ patents, is similar enough to the same concern of the
`
`Plaintiffs and the declaratory relief Intervenors seek.
`
`Asthe sole recipients/targets for Moderna’s COVID-19 vaccines, each citizen
`
`of the United States, pursuant to the “powers” reserved under the Tenth
`
`Amendment, would be the primary and sole enforcer of Moderna’s productliability
`
`for its COVID-19 vaccines.
`
`Moreover, the course ofthis litigation, which has been abruptly changed with
`
`Moderna’s counterclaim and the statementof interest by the United States,
`
`significantly demonstrates the existing parties represent only their interests.
`
`Thus, a threat is created that the interests of the Intervenors will be impaired
`
`or affected by the disposition of the underlying action, particularly should the
`
`disposition fail to deny Moderna’s unlawful attemptto shift liability to the United
`
`States. See Liberty Mut. Ins., 419 F.3d at 220. Moreover, furtherlitigation is on hold
`
`pendingletters regarding the “scheduling of this matter.” (Doc. 51).
`
`Ill. Article ITI Standing To Intervene.
`
`To have standing to sue as a class representative it is essential that a party
`
`must be a part of that class, that is, he must possess the sameinterest and suffer the
`
`same injury shared by all members ofthe class he represents. To state differently,
`
`proposed Intervenors’ interest must be “undifferentiated” from that of all other
`
`
`
`Caffe 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 6 of 9 PagelD #: 1099
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 6 of 9 PageID #: 1099
`
`—
`
`2
`
`residents of the United States. Schlesinger v. Reservists to Stop the War, 418 U.S.
`
`208, 216 (1974). See also Town of Chester v. Laroe Estates, Inc., 1378. Ct. 1645,
`
`3 4|
`
`|1650 (2017) (“Article III of the Constitution limits the exercise of the judicial power
`
`>||to ‘Cases’ and ‘Controversies.’” (Citation omitted).
`
`The concrete injury here asserted has been alleged in Plaintiff's Complaint:
`
`“Moderna brought its vaccine from lab bench to arms in record speed.
`That unprecedented accomplishment was madepossible by Moderna’s
`use of breakthrough technology Arbutus had already created and
`patented—a revolutionary lipid nanoparticle (“LNP”) delivery platform
`that took the scientists of Arbutus years of painstaking work to develop
`and refine. Moderna was well aware of Arbutus’s LNP patents and
`licensed them for other product programs,but it chose notto do so for
`its COVID-19 vaccine.” Jd. J 1.
`
`“Without adequate protection, mRNA quickly degrades in the body.
`For mRNAvaccines like Moderna’s to work, they must incorporate a
`mechanism for protecting the fragile mRNA,delivering it through cell
`membranes, and then releasing it inside the cell. In the words of one
`Nobel Prize winningscientist, the secret for making RNA-based
`products work has always been “delivery, delivery, delivery. Jd. § 3.
`
`6
`
`7 8
`
`9
`10
`
`ie
`12
`
`13
`
`14
`
`15
`16
`
`17
`18
`
`Moderna’s alleged patent infringements; Moderna’s highly volatile COVID-
`19
`29||19 vaccines; Moderna’s counterclaim and the United States’ Statement of Interest
`
`seeking to transfer liability to the United States, combineto significantly complicate
`
`21
`
`22
`
`the chain of product and Governmenttort liability associated with the Federal class
`33
`24||tort claimsfiled by putative class members Jerzy Gruca (“Gruca”), HHS
`
`25||Administrative Tort Claim No. 2021-0064; Emanuel McCray, HHS Administrative
`
`
`
`Cale 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 7 of 9 PagelD #: 1100
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 7 of 9 PageID #: 1100
`
`wa&WwHN—
`oOoSoNDS
`
`Tort Claim No. 2020-1415,° and others, for the case Marta Reyes,et al. v. Republic
`
`ofChina, et al., Class Action No. 20-cv-21108-AMCin the U.S. District Court for
`
`the Southern District of Florida (Miami), filed on March 12, 2020.
`
`The Miamiclass action is currently on administrative hold to allow the
`
`Plaintiffs time to “Continue Service of Process Pursuant To The FSIA”against the
`
`Peoples Republic of China, et al. and to amend the Complaint by “expand[ing] the
`
`factual allegations of how the pandemic unfolded and how agents and actors of
`
`Defendants committed wrongful acts within the United States...since the research
`
`for the April 15" [2021] brief does appear to lead to additional U.S. based
`
`defendants who acted on behalf of or in aid of China to further the pandemic....” Jd.
`
`{7 6-9.
`
`Anyshift of patent infringementliability from Moderna to the United States
`
`would arguably affect the class action tort claims filed against the United States and
`
`the allegations of how CCPactors and agents within the United States conducted
`
`themselves and furthered the pandemic, including Moderna’s infringement of
`
`Plaintiffs’ patents and the safety and efficacy of Defendants’ vaccinesthat are
`
`delivered by Plaintiffs’ vaccine delivery vehicles.
`
`3 See Exhibit 3 to Intervenors’ Complaint (Letter from Department of Health and HumanServices).
`
`7
`
`
`
`Cate 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 8 of 9 PagelD #: 1101
`Case 1:22-cv-00252-MSG Document 60 Filed 03/02/23 Page 8 of 9 PageID #: 1101
`
`moS&SKNDRASeWwNY
`
`—tesyoShUO
`
`13
`
`IV.
`
`Permissive Intervention.
`
`The proposedIntervenorsalso satisfy the requirements for permissive
`
`intervention, which is governed by the provisions of Fed. R. Civ. P. Rule 24(b).
`
`Proposed Intervenors can assert both factual and legal questions directly
`
`related to the main action, Defendants’ counterclaim, and the United States’
`
`statementofinterest.
`
`The proposed Intervenors simply seek to protect our “health and well-being”
`
`and ourindividual sovereignty. Intervention will significantly contribute to the just
`
`and equitable adjudication of the legal questions thus presented.
`
`VII. CONCLUSION.
`
`For the reasons set forth above, the proposed Intervenors-Plaintiffs
`
`respectfully request that the Court grant their motion to interveneas of right, or, in
`
`the alternative, allow the Proposed Intervenors-Plaintiffs to intervene permissively.
`
`Respectfully submitted this 26" day of February 2023.
`
`Emanuel McCray
`
`a
`
`2700 Caples Street
`P.O. Box 3134
`Vancouver, WA 98668
`(564) 208-7576
`emanuel.mccray@hotmail.com
`
`
`
`
`
`
`|
`
`Fac 6118918
`
`SS. POSTAGE
`$9.65
`PM
`98661
`Date of sale ¥
`02/26/23 %
`02
`Bw
`
`
`EMANUEL MCCRAY
`
`PO BOX 3134
`VANCOUVER WA 98668-3134
`
`EXPECTED DELIVERY DAY: 03/02/23
`
`SHIP,
`
`@ When
` *Insurance
`Domestic
`** See inte
`
`US DISTRICT COURT
`844 N KING ST
`WILMINGTON DE 19801-3519
`
`
`9505 5066 7171 3057 8035 18
`
`
`
`strictions apply).*
`
`al destinations.
`
`uired.
`
`1s see the
`
`itions of coverage.
`
`PS00001000014
`
`EP14F May 2020
`OD: 12 1/2x9 1/2
`
`USPS.COM/PICKUP
`
`
`
`
`
`
`
`QBUapOADIZMOY|
`
`
`P
` PRESSFIRMLY TO SEAL
`FLAT RATE ENVELOPE\.
`
`
`aBaort
`POSTAGE REQUIRED
`
`
`9819700774 913030226211658
`
`
`
`
`
`:
`
`TRACKING® NUMBERTa
`
`
`2 free Package Pickup,
`
`WO UMN
`
`
`
`
`
`iandPriorityMailInternational®shiprients.
`
`
`
`May2020;Allrightsreserved.
`
`
`EP14F©U.S.PostalService;
`
`
`
`ice®andisprovidedsolelyforuseinsendingPriorityMal
`
`
`
`
`Misusesmaybeaviolationoffederallaw.Thispackageisnotforresale.
`
`
`=ThispackagingIsthepropertyoftheU.S.PostalServ
`
`
`PRESS FIRMLY TO SEAL
`
`_ Emanuel McCray
`2700 Caples Street
`P.O. Box 3134
`Vancouver, WA 98668 ©
`
` |
`
`usDISTRCT COURT |
`|DISTRICTOF DELAWARE |
`
`TO:
`
`OFFICE OF THE CLERK
`United States District Court
`i 844 North King Street Unit 18 .
`Wilmington, DE 19801-3570 _
`
`
`
`
`
`